|
Site Efficiency.
ERGOMED’s patient-per-site ratio is exceptional. Historically,
in the cases where ERGOMED has undertaken studies jointly and in
collaboration with other CROs, 20% of these sites have been managed
by ERGOMED, yet ERGOMED’s sites have contributed approximately
30% of the total number of patient subjects. Typically, the subject-to-site
ratio of ERGOMED-managed sites has been over double that of the
other CROs.
Site efficiency means
• lower costs,
• shorter timelines and
• higher quality data.
|
